Filing Details
- Accession Number:
- 0001209191-22-000164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-03 16:22:59
- Reporting Period:
- 2021-12-28
- Accepted Time:
- 2022-01-03 16:22:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 822370 | Emmaus Life Sciences Inc. | EMMA | Pharmaceutical Preparations (2834) | 870419387 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1517691 | Yutaka Niihara | 21250 Hawthorne Blvd. Suite 800 Torrance CA 90503 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2021-12-28 | 1,000 | $1.60 | 11,125,656 | No | 4 | P | Direct | |
| Common Stock, $0.001 Par Value | Acquisiton | 2021-12-29 | 2,700 | $1.57 | 11,128,356 | No | 4 | P | Direct | |
| Common Stock, $0.001 Par Value | Acquisiton | 2021-12-30 | 6,800 | $1.56 | 11,135,156 | No | 4 | P | Direct | |
| Common Stock, $0.001 Par Value | Acquisiton | 2021-12-31 | 7,000 | $1.58 | 11,142,156 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.001 Par Value | 92,794 | Indirect | By Hope International Hospice, Inc. |
| Common Stock, $0.001 Par Value | 63,000 | Indirect | By Soomi Niihara |
Footnotes
- The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.52 to $1.65, inclusive.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.65, inclusive.
- Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.
Billionaire Hedge Funds
